Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Fluoxetine (Generic Health) TM
Active ingredients: fluoxetine
What it is used for
Major depression. Obsessive Compulsive Disorder. Premenstrual Dysphoric Disorder (PMDD) as defined by DSM-IV criteria.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Light green/off-white size 3 capsule containing white powder
Images are the copyright of the Pharmacy Guild of Australia
Food interactions
For the active ingredient fluoxetine
- Avoid alcohol.
- Take with food to reduce irritation and nausea.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient fluoxetine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Depression - Orygen, The National Centre of Excellence in Youth Mental Health
Orygen, The National Centre of Excellence in Youth Mental Health is the world’s leading research and knowledge translation organisation focusing on mental ill-health in young people.
Read more on Orygen, The National Centre of Excellence in Youth Mental Health website
Eating Disorders - Orygen, The National Centre of Excellence in Youth Mental Health
Orygen, The National Centre of Excellence in Youth Mental Health is the world’s leading research and knowledge translation organisation focusing on mental ill-health in young people.
Read more on Orygen, The National Centre of Excellence in Youth Mental Health website
Sleep disturbances in menopause | myVMC
Women are more likely to experience sleep disturbances in the menopausal period than at other times of life. Poor quality sleep is a common complaint amongst menopausal women, of whom 2550% report sleep difficulties, compared to some 15% of the general population.
Read more on myVMC – Virtual Medical Centre website
PBS for pharmacists - Australian Government Department of Human Services
Department of Human Services can grant pharmacists approval to supply Pharmaceutical Benefits Scheme (PBS) subsidised items in accordance with section 90 of the National Health Act 1953.
Read more on Medicare website
Quitting smoking: Managing the associated mood changes | myVMC
For some, smoking is used as an avenue to relieve negative moods, to relax and reduce emotional distress. While smoking may appear to provide these psychological benefits, it is also associated with increased levels of stress and depression. Smokers report high or very high levels of psychological distress 20% of the time, compared to 10% of the time in non-smokers.
Read more on myVMC – Virtual Medical Centre website
Raynaud's Phenomenon Raynaud's disease | myVMC
Medical information about Raynaud's disease constriction of blood vessel in Raynauds Syndrome symptoms of Raynaud's phenomenon treatment
Read more on myVMC – Virtual Medical Centre website
Curcumin - BluePages
Find out if curcumin is likely to help.
Read more on e-hub Web Services - Australian National University (ANU) website
Raynaud's phenomenon (Raynaud's disease) information | myVMC
Raynaud's phenomenon causes narrowing of the blood vessels, leading to impaired blood supply and tissue death in fingers, toes, ears and nose.
Read more on myVMC – Virtual Medical Centre website
Selective serotonin reuptake inhibitors (SSRIs) for depression - myDr.com.au
Selective serotonin reuptake inhibitors (SSRIs) are medicines used to treatdepression and anxiety. In fact, they are the most commonly prescribed type of antidepressant medicine in Australia.&nb
Read more on myDr website
Bulimia (binge eating disorder) information | myVMC
Bulimia nervosa is a psychological disease characterised by episodic, uncontrolled binge eating, followed by self-induced vomiting to avoid weight gain.
Read more on myVMC – Virtual Medical Centre website
Top results
Fluoxetine compared with other antidepressants for depression in adults | Cochrane
Depression is a severe mental illness characterised by a persistent low mood and loss of all interest and pleasure, usually accompanied by a range of symptoms such as appetite change, sleep disturbance and poor concentration. The predominant treatment options for depression are drugs and psychological therapies, but antidepressant drugs are the most common treatment for moderate to severe depression. Fluoxetine, one of the first new generation antidepressants, is an extremely popular drug treatment for depression. However, findings from studies comparing fluoxetine with other antidepressants are controversial. In this systematic review, the efficacy and tolerability of fluoxetine was compared with other antidepressants for the acute treatment of depression.
Read more on Cochrane (Australasian Centre) website
Second-generation antidepressants for winter depression | Cochrane
Seasonal affective disorder (winter depression) is a type of depression that recurs in the autumn and lasts until the spring. It is similar to regular depression except sufferers are usually very tired and have an increase in their appetite. It is more common in countries with few daylight hours in winter. One of the mainstays of treatment for all depression, including winter depression, are second-generation antidepressants (SGAs) such as selective serotonin reuptake inhibitors (SSRIs), and serotonin and norepinephrine reuptake inhibitors (SNRIs). It is not clear how well these drugs work for winter depression and how they compare to each other or to other types of therapy such as light therapy.
Read more on Cochrane (Australasian Centre) website
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus | Cochrane
Obesity is closely related to type 2 diabetes and weight reduction is an important part of the care delivered to obese persons with diabetes. This review of drugs for weight loss among adults with type 2 diabetes revealed weight loss of between 2.0 and 5.1 kg for fluoxetine, orlistat and sibutramine at follow-up of up to 57 weeks. The long-term effects remain uncertain. Adverse events were common in all three drugs: gastrointestinal side effects with orlistat; tremor, somnolence, and sweating with fluoxetine; and palpitations with sibutramine. There were few studies examining other drugs used for weight loss in populations with diabetes.
Read more on Cochrane (Australasian Centre) website
Selective serotonin reuptake inhibitors (SSRIs) for fibromyalgia | Cochrane
Researchers of the Cochrane Collaboration conducted a review of research about the effects of antidepressants classified as serotonin reuptake inhibitors (SSRIs) on fibromyalgia. After searching for all relevant studies up to June 2014, they found seven studies that compared SSRIs with a fake medication. These studies included a total of 383 people. Most participants were middle-aged women. The SSRIs that they studied were citalopram, fluoxetine and paroxetine. Five studies were each funded by pharmaceutical companies, and two studies were funded by public institutions.
Read more on Cochrane (Australasian Centre) website
Drugs in breastfeeding | Issue 5 | Volume 38 | Australian Prescriber
Most commonly used drugs are relatively safe for breastfed babies. The dose received via milk is generally small and much less than the known safe doses of...
Read more on Australian Prescriber website
Assessing depressive symptoms in young people - A guide for primary care health professionals
When young people are experiencing distress or depressive symptoms, there may be explanations other than depression, such as grief and loss, trauma or distressing life events, or difficulties in expressing and managing anger, sadness, fear and shame
Read more on beyondblue website
Depression in young people - A desktop guide for primary health care professionals
A summary of the Clinical Practice Guidelines: Depression in adolescents and young adults
Read more on beyondblue website
Compulsions | CRUfAD
CONTACT US URGENT CARE About Us Our Research For Patients For Clinicians Select Page Compulsions OCD Pages 271-276 from the Management of Mental Disorders, published by World Health Organization, Sydney
Read more on CRUfAD – Clinical Research Unit for Anxiety and Depression website
Switching and stopping antidepressants | Issue 3 | Volume 39 | Australian Prescriber
Switching people from one antidepressant to another is commonly needed but can cause drug withdrawal symptoms, drug interactions and relapse in depression....
Read more on Australian Prescriber website
Combining two or more drugs vs one drug for pain control in inflammatory arthritis | Cochrane
This summary of a Cochrane review presents what we know from research about the effect of a combination of two pain relieving drugs for pain control in inflammatory arthritis (IA).
Read more on Cochrane (Australasian Centre) website
